Nrx pharmaceuticals (nasdaq:nrxp) announces plan to distribute shares of hope therapeutics and royalty rights on ketamine sales to existing nrx shareholders

Nrx pharmaceuticals board of directors has authorized its chairman, ceo, and management to take all necessary steps to affect the dividend and royalty rights to nrxp shareholders and applicable warrant holders dividend is intended to distribute 49% of hope therapeutics stock and a royalty right for 1% of ketamine sales made by hope effective date to be declared as soon as all required legal, accounting, and regulatory steps have been completed proxy voting instructions included below radnor, pa. , march 18, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company") today announced that its board of directors (board) has authorized its chairman and management to take all necessary steps to affect a dividend of hope therapeutics ("hope") stock along with a royalty right of 1% of ketamine sales to nrxp shareholders and applicable warrant holders.
NRXP Ratings Summary
NRXP Quant Ranking